Deans' stroke musings: CXCL12/CXCR4/CXCR7 Chemokine Axis in the Central Nervous System Therapeutic Targets for Remyelination in Demyelinating Diseases

Changing stroke rehab and research worldwide now.Time is Brain! trillions and trillions of neurons that DIE each day because there are NO effective hyperacute therapies besides tPA(only 12% effective). I have 523 posts on hyperacute therapy, enough for researchers to spend decades proving them out. These are my personal ideas and blog on stroke rehabilitation and stroke research. Do not attempt any of these without checking with your medical provider. Unless you join me in agitating, when you need these therapies they won't be there.

What this blog is for:

My blog is not to help survivors recover, it is to have the 10 million yearly stroke survivors light fires underneath their doctors, stroke hospitals and stroke researchers to get stroke solved. 100% recovery. The stroke medical world is completely failing at that goal, they don't even have it as a goal. Shortly after getting out of the hospital and getting NO information on the process or protocols of stroke rehabilitation and recovery I started searching on the internet and found that no other survivor received useful information. This is an attempt to cover all stroke rehabilitation information that should be readily available to survivors so they can talk with informed knowledge to their medical staff. It lays out what needs to be done to get stroke survivors closer to 100% recovery. It's quite disgusting that this information is not available from every stroke association and doctors group.

Saturday, January 14, 2017

CXCL12/CXCR4/CXCR7 Chemokine Axis in the Central Nervous System Therapeutic Targets for Remyelination in Demyelinating Diseases

I still don't know if stroke causes demyelination. Ask your doctor and if it does, What stroke protocols are there to remyelinate?

Show all authors

Tianci Chu, Lisa B. E. Shields, Yi Ping Zhang, Shi-Qing Feng, Christopher B. Shields, Jun Cai

First Published January 10, 2017 review-article

Abstract

The chemokine CXCL12 plays a vital role in regulating the development of the central nervous system (CNS) by binding to its receptors CXCR4 and CXCR7. Recent studies reported that the CXCL12/CXCR4/CXCR7 axis regulates both embryonic and adult oligodendrocyte precursor cells (OPCs) in their proliferation, migration, and differentiation. The changes in the expression and distribution of CXCL12 and its receptors are tightly associated with the pathological process of demyelination in multiple sclerosis (MS), suggesting that modulating the CXCL12/CXCR4/CXCR7 axis may benefit myelin repair by enhancing OPC recruitment and differentiation. This review aims to integrate the current findings of the CXCL12/CXCR4/CXCR7 signaling pathway in the CNS and to highlight its role in oligodendrocyte development and demyelinating diseases. Furthermore, this review provides potential therapeutic strategies for myelin repair by analyzing the relevance between the pathological changes and the regulatory roles of CXCL12/CXCR4/CXCR7 during MS.

References

	Alsayed Y, Ngo H, Runnels J, Leleu X, Singha UK, Pitsillides CM, and others. 2007. Mechanisms of regulation of CXCR4/SDF-1 (CXCL12)-dependent migration and homing in multiple myeloma. Blood 109(7):2708–17. , Google Scholar Medline
	Arakawa Y, Bito H, Furuyashiki T, Tsuji T, Takemoto-Kimura S, Kimura K, and others. 2003. Control of axon elongation via an SDF-1alpha/Rho/mDia pathway in cultured cerebellar granule neurons. J Cell Biol 161(2):381–91. , Google Scholar CrossRef, Medline
	Back SA, Tuohy TM, Chen H, Wallingford N, Craig A, Struve J, and others. 2005. Hyaluronan accumulates in demyelinated lesions and inhibits oligodendrocyte progenitor maturation. Nat Med 11(9):966–72. , Google Scholar Medline
	Baggiolini M. 1998. Chemokines and leukocyte traffic. Nature 392(6676):565–8. , Google Scholar CrossRef, Medline
	Bajetto A, Barbero S, Bonavia R, Piccioli P, Pirani P, Florio T, and others. 2001. Stromal cell-derived factor-1α induces astrocyte proliferation through the activation of extracellular signal-regulated kinases 1/2 pathway. J Neurochem 77(5):1226–36. , Google Scholar CrossRef, Medline
	Bajetto A, Bonavia R, Barbero S, Piccioli P, Costa A, Florio T, and others. 1999. Glial and neuronal cells express functional chemokine receptor CXCR4 and its natural ligand stromal cell-derived factor 1. J Neurochem 73(6):2348–57. , Google Scholar CrossRef, Medline
	Balabanian K, Lagane B, Infantino S, Chow KY, Harriague J, Moepps B, and others. 2005. The chemokine SDF-1/CXCL12 binds to and signals through the orphan receptor RDC1 in T lymphocytes. J Biol Chem 280(42):35760–6. , Google Scholar CrossRef, Medline
	Banisadr G, Frederick TJ, Freitag C, Ren D, Jung H, Miller SD, and others. 2011. The role of CXCR4 signaling in the migration of transplanted oligodendrocyte progenitors into the cerebral white matter. Neurobiol Dis 44(1):19–27. , Google Scholar Medline
	Banisadr G, Podojil JR, Miller SD, Miller RJ. 2016. Pattern of CXCR7 gene expression in mouse brain under normal and inflammatory conditions. J Neuroimmune Pharmacol 11(1):26–35. , Google Scholar CrossRef, Medline
	Banisadr G, Skrzydelski D, Kitabgi P, Rostene W, Parsadaniantz SM. 2003. Highly regionalized distribution of stromal cell-derived factor-1/CXCL12 in adult rat brain: constitutive expression in cholinergic, dopaminergic and vasopressinergic neurons. Eur J Neurosci 18(6):1593–606. , Google Scholar CrossRef, Medline
	Barnett MH, Prineas JW. 2004. Relapsing and remitting multiple sclerosis: pathology of the newly forming lesion. Ann Neurol 55(4):458–68. , Google Scholar CrossRef, Medline
	Bø L, Esiri M, Evangelou N, Kuhlmann T. 2013. Demyelination and remyelination in multiple sclerosis. In: Duncan ID, Franklin RJM, editors. Myelin repair and neuroprotection in multiple sclerosis. New York: Springer. p. 23-45. , Google Scholar CrossRef
	Boldajipour B, Mahabaleshwar H, Kardash E, Reichman-Fried M, Blaser H, Minina S, and others. 2008. Control of chemokine-guided cell migration by ligand sequestration. Cell 132(3):463–73. , Google Scholar CrossRef, Medline
	Boyd A, Zhang H, Williams A. 2013. Insufficient OPC migration into demyelinated lesions is a cause of poor remyelination in MS and mouse models. Acta Neuropathol 125(6):841–59. , Google Scholar CrossRef, Medline
	Bramow S, Frischer JM, Lassmann H, Koch-Henriksen N, Lucchinetti CF, Sorensen PS, and others. 2010. Demyelination versus remyelination in progressive multiple sclerosis. Brain 133(10):2983–98. , Google Scholar CrossRef, Medline
	Burns JM, Summers BC, Wang Y, Melikian A, Berahovich R, Miao Z, and others. 2006. A novel chemokine receptor for SDF-1 and I-TAC involved in cell survival, cell adhesion, and tumor development. J Exp Med 203(9):2201–13. , Google Scholar CrossRef, Medline
	Busillo JM, Benovic JL. 2007. Regulation of CXCR4 signaling. Biochim Biophys Acta 1768(4):952–63. , Google Scholar CrossRef, Medline
	Calderon TM, Eugenin EA, Lopez L, Kumar SS, Hesselgesser J, Raine CS, and others. 2006. A role for CXCL12 (SDF-1α) in the pathogenesis of multiple sclerosis: regulation of CXCL12 expression in astrocytes by soluble myelin basic protein. J Neuroimmunol 177(1-2):27–39. , Google Scholar CrossRef, Medline
	Cantarella C, Cayre M, Magalon K, Durbec P. 2008. Intranasal HB-EGF administration favors adult SVZ cell mobilization to demyelinated lesions in mouse corpus callosum. Dev Neurobiol 68(2):223–36. , Google Scholar CrossRef, Medline
	Carbajal KS, Miranda JL, Tsukamoto MR, Lane TE. 2011. CXCR4 signaling regulates remyelination by endogenous oligodendrocyte progenitor cells in a viral model of demyelination. Glia 59(12):1813–21. , Google Scholar CrossRef, Medline
	Carbajal KS, Schaumburg C, Strieter R, Kane J, Lane TE. 2010. Migration of engrafted neural stem cells is mediated by CXCL12 signaling through CXCR4 in a viral model of multiple sclerosis. Proc Natl Acad Sci U S A 107(24):11068–73. , Google Scholar CrossRef, Medline
	Carson MJ, Behringer RR, Brinster RL, McMorris FA. 1993. Insulin-like growth factor I increases brain growth and central nervous system myelination in transgenic mice. Neuron 10(4):729–40. , Google Scholar CrossRef, Medline
	Ceradini DJ, Kulkarni AR, Callaghan MJ, Tepper OM, Bastidas N, Kleinman ME, and others. 2004. Progenitor cell trafficking is regulated by hypoxic gradients through HIF-1 induction of SDF-1. Nat Med 10(8):858–64. , Google Scholar CrossRef, Medline
	Chang A, Tourtellotte WW, Rudick R, Trapp BD. 2002. Premyelinating oligodendrocytes in chronic lesions of multiple sclerosis. N Engl J Med 346(3):165–73. , Google Scholar CrossRef, Medline
	Chari DM, Blakemore WF. 2002. New insights into remyelination failure in multiple sclerosis: implications for glial cell transplantation. Mult Scler 8(4):271–7. , Google Scholar Link
	Chen Q, Zhang M, Li Y, Xu D, Wang Y, Song A, and others. 2015. CXCR7 mediates neural progenitor cells migration to CXCL12 independent of CXCR4. Stem Cells 33(8):2574–85. , Google Scholar CrossRef, Medline
	Chrast R, Saher G, Nave KA, Verheijen MH. 2011. Lipid metabolism in myelinating glial cells: lessons from human inherited disorders and mouse models. J Lipid Res 52(3):419–34. , Google Scholar CrossRef, Medline
	Chu T, Zhou H, Li F, Wang T, Lu L, Feng S. 2014. Astrocyte transplantation for spinal cord injury: current status and perspective. Brain Res Bull 107:18–30. , Google Scholar CrossRef, Medline
	Connick P, Kolappan M, Patani R, Scott MA, Crawley